Practice Point | Published:

Does tamoxifen prophylaxis for breast cancer provide long-term prevention?

Nature Clinical Practice Oncology volume 4, pages 568569 (2007) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. (2002) First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 360: 817–824

  2. 2.

    et al. (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346: 1616–1622

  3. 3.

    et al. (2007) Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. J Natl Cancer Inst 99: 283–290

  4. 4.

    et al. (2007) Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy. J Natl Cancer Inst 99: 727–737

  5. 5.

    et al. (2005) Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 97: 1652–1662

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Affiliations

  1. B Bonanni is Co-Director of the Division of Cancer Prevention and Genetics, M Lazzeroni is a Fellow, and U Veronesi is Scientific Director, at the European Institute of Oncology, Milan, Italy.

    • Bernardo Bonanni
    • , Matteo Lazzeroni
    •  & Umberto Veronesi

Authors

  1. Search for Bernardo Bonanni in:

  2. Search for Matteo Lazzeroni in:

  3. Search for Umberto Veronesi in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Umberto Veronesi.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/ncponc0933

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing